AUB ScholarWorks

Two successful pregnancies in a patient with chemotherapy-induced ovarian failure while on hormone replacement therapy

Show simple item record Ghazeeri G. Awwad J.
dc.contributor.editor 2012 2017-10-05T15:46:51Z 2017-10-05T15:46:51Z 2012
dc.identifier 10.3109/09513590.2011.633657
dc.identifier.issn 09513590
dc.description.abstract Chemotherapeutic agents administered for the treatment of malignancies can result in the incidence of premature ovarian failure (POF). Ovarian failure is reflected by elevated serum follicle-stimulating hormone (FSH) levels that may reach menopausal levels, at which the chances of a pregnancy are considered extremely rare. We report a case of a 26-year-old female who experienced two successful pregnancies, despite her diagnosis with chemotherapy-induced POF. This case suggests that patients who suffer from POF secondary to chemotherapy might still retain enough ovarian function with good quality oocytes that could support a healthy pregnancy.
dc.format.extent Pages: (286-287)
dc.language English
dc.publisher NEW YORK
dc.relation.ispartof Publication Name: Gynecological Endocrinology; Publication Year: 2012; Volume: 28; no. 4; Pages: (286-287);
dc.source Scopus
dc.title Two successful pregnancies in a patient with chemotherapy-induced ovarian failure while on hormone replacement therapy
dc.type Article
dc.contributor.affiliation Ghazeeri, G., Department of Obstetrics and Gynecology, American University, Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Awwad, J., Department of Obstetrics and Gynecology, American University, Beirut Medical Center, Beirut, Lebanon
dc.contributor.authorAddress Ghazeeri, G.; Department of Obstetrics and Gynecology, American University, Beirut Medical Center, Beirut, Lebanon; email:
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Obstetrics and Gynecology;
dc.contributor.authorDepartment Obstetrics and Gynecology
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Ghazeeri, G
dc.contributor.authorInitials Awwad, J
dc.contributor.authorReprintAddress Ghazeeri, G (reprint author), Amer Univ Beirut, Med Ctr, Dept Obstet and Gynecol, POB 11-0236, Beirut 11072020, Lebanon.
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016-S0015-0282(98)00099-5; Aslam M F, 2004, J Obstet Gynaecol, V24, P573; Bidet M, 2008, CURR OPIN OBSTET GYN, V20, P416, DOI 10.1097-GCO.0b013e328306a06b; Chasle Sharon, 2003, Eur J Oncol Nurs, V7, P91, DOI 10.1016-S1462-3889(02)00081-9; Check JH, 2008, CLIN EXP OBSTET GYN, V35, P10; Conway GS, 2000, BRIT MED BULL, V56, P643, DOI 10.1258-0007142001903445; Dragojevic-Dikic S, 2009, GYNECOL ENDOCRINOL, V25, P769, DOI 10.3109-09513590903004126; Fernandes AMD, 2002, J REPROD MED, V47, P504; Gelbaya T, 2011, GYNECOL ENDOCRINOL, V27, P1, DOI 10.3109-09513590.2010.501875; Hensley ML, 1998, CRIT REV ONCOL HEMAT, V28, P121, DOI 10.1016-S1040-8428(98)00013-4; KREINER D, 1988, OBSTET GYNECOL, V72, P926; Levi AJ, 2001, FERTIL STERIL, V76, P666, DOI 10.1016-S0015-0282(01)02017-9; Liu J, 2008, BONE MARROW TRANSPL, V41, P275, DOI 10.1038-sj.bmt.1705893; Menashe Y, 1996, J REPROD MED, V41, P207; Nasir J, 1997, CLIN ENDOCRINOL, V46, P217, DOI 10.1046-j.1365-2265.1997.771575.x; Posada MN, 2001, FERTIL STERIL, V75, P647, DOI 10.1016-S0015-0282(00)01781-7; Rebar RW, 2008, ANN NY ACAD SCI, V1135, P138, DOI 10.1196-annals.1429.000; Rebar RW, 2009, OBSTET GYNECOL, V113, P1355, DOI 10.1097-AOG.0b013e3181a66843; Rosendahl M, 2010, FERTIL STERIL, V94, P156, DOI 10.1016-j.fertnstert.2009.02.043; Selvaraj Priya, 2010, J Hum Reprod Sci, V3, P35, DOI 10.4103-0974-1208.63121; Stroud JS, 2009, FERTIL STERIL, V92, P417, DOI 10.1016-j.fertnstert.2008.07.1714; Vandborg M., 2006, Archives of Gynecology and Obstetrics, V273, P387, DOI 10.1007-s00404-005-0096-9
dc.description.citedTotWOSCount 1
dc.description.citedWOSCount 1
dc.format.extentCount 2
dc.identifier.coden GYENE
dc.identifier.scopusID 84858391147
dc.publisher.address 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
dc.relation.ispartOfISOAbbr Gynecol. Endocrinol.
dc.relation.ispartOfIssue 4
dc.relation.ispartofPubTitle Gynecological Endocrinology
dc.relation.ispartofPubTitleAbbr Gynecol. Endocrinol.
dc.relation.ispartOfVolume 28
dc.source.ID WOS:000301588400011
dc.type.publication Journal
dc.subject.otherAuthKeyword Chemotherapy
dc.subject.otherAuthKeyword Hormone replacement therapy
dc.subject.otherAuthKeyword Pregnancy
dc.subject.otherAuthKeyword Premature ovarian failure
dc.subject.otherChemCAS cyclophosphamide, 50-18-0
dc.subject.otherChemCAS dactinomycin, 1402-38-6, 1402-58-0, 50-76-0
dc.subject.otherChemCAS doxorubicin, 23214-92-8, 25316-40-9
dc.subject.otherChemCAS estradiol, 50-28-2
dc.subject.otherChemCAS estradiol valerate plus norgestrel, 65394-89-0
dc.subject.otherChemCAS etoposide, 33419-42-0
dc.subject.otherChemCAS follitropin, 9002-68-0
dc.subject.otherChemCAS ifosfamide, 3778-73-2
dc.subject.otherChemCAS irinotec
dc.subject.otherIndex cyclophosphamide
dc.subject.otherIndex dactinomycin
dc.subject.otherIndex doxorubicin
dc.subject.otherIndex estradiol
dc.subject.otherIndex estradiol valerate plus norgestrel
dc.subject.otherIndex etoposide
dc.subject.otherIndex follitropin
dc.subject.otherIndex ifosfamide
dc.subject.otherIndex irinotecan
dc.subject.otherIndex luteinizing hormone
dc.subject.otherIndex progesterone
dc.subject.otherIndex vincristine
dc.subject.otherIndex adult
dc.subject.otherIndex adverse drug reaction
dc.subject.otherIndex amenorrhea
dc.subject.otherIndex article
dc.subject.otherIndex cancer chemotherapy
dc.subject.otherIndex cancer recurrence
dc.subject.otherIndex case report
dc.subject.otherIndex chemotherapy induced ovarian failure
dc.subject.otherIndex evisceration
dc.subject.otherIndex female
dc.subject.otherIndex hormone determination
dc.subject.otherIndex hormone substitution
dc.subject.otherIndex human
dc.subject.otherIndex menopausal syndrome
dc.subject.otherIndex ovary insufficiency
dc.subject.otherIndex pregnancy
dc.subject.otherIndex priority journal
dc.subject.otherIndex rhabdomyosarcoma
dc.subject.otherIndex treatment response
dc.subject.otherKeywordPlus OVULATION INDUCTION
dc.subject.otherKeywordPlus CANCER
dc.subject.otherKeywordPlus WOMAN
dc.subject.otherKeywordPlus FERTILITY
dc.subject.otherKeywordPlus RECOVERY
dc.subject.otherWOS Endocrinology and Metabolism
dc.subject.otherWOS Obstetrics and Gynecology

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


My Account